Intellectual Property

  • October 30, 2024

    Suit Says Print Shop Stole Watermarked Pics For Contract Bid

    An advertising firm is taking a printing and promotions shop to North Carolina federal court after the printer allegedly misappropriated photos of the ad company's camouflage products and used them to try to score a merchandising deal with the Missouri Army National Guard despite one picture bearing its actual owner's watermark.

  • October 30, 2024

    Eyelash Biz Wants Albright To Triple $31M Patent Verdict

    A California company that sells do-it-yourself eyelash extension kits is asking U.S. District Judge Alan Albright to triple a nearly $31 million willful patent infringement verdict against a Chinese rival that "intentionally flooded the market with 632 models of infringing products."

  • October 30, 2024

    Cannabis Fertilizer Co. Can Mostly Bar Rival's IP Theft In Ads

    A Seattle federal judge has curtailed a fertilizer manufacturer's use of a rival's name in marketing its cannabis-focused products, saying he found it "problematic" that the company's messaging suggests using both products in tandem.

  • October 30, 2024

    IBM Wants Extra $63M From Zynga After $45M App Patent Win

    IBM Corp. asked a Delaware federal judge to add $63 million in enhancement and prejudgment interest onto its $45 million patent infringement award against Zynga Inc., a week after Zynga asked the court to order a new trial over the dispute.

  • October 30, 2024

    Historic World Series Prompts Flagrant IP Theft, MLB Says

    A World Series matchup between two of baseball's most storied franchises has fueled a boom in sales of counterfeit apparel, Major League Baseball's media arm has told a New York federal court, identifying several pockets of New York City as hubs for the illicit merchandise.

  • October 30, 2024

    DLA Piper's FDA Regulation Vice Chair Joins White & Case

    The former vice chair of DLA Piper's FDA regulatory practice has joined White & Case LLP's global life sciences and healthcare group and intellectual property practice.

  • October 30, 2024

    Conn. Judge Cites Day Pitney Ties In Lego Settlement Recusal

    U.S. Magistrate Judge Thomas O. Farrish has recused himself from presiding over settlement talks between Lego and a New York artist who is suing the toy company over a play set based on the Netflix series "Queer Eye," citing the fact that his former firm, Day Pitney LLP, represents the defendants.

  • October 29, 2024

    Bell Owes $16M In Trade Secrets Row With Vendor, Jury Finds

    A Texas jury on Tuesday largely found in favor of Bell Helicopter Textron Inc. in a suit claiming that it used a former vendor's trade secrets to prep a replacement supplier, concluding that Bell breached its contract with the vendor but that the Fort Worth, Texas-based aerospace manufacturer hadn't stolen intellectual property.

  • October 29, 2024

    Retired Fed. Circ. Judge Backs Invisalign In Monopoly Cases

    Retired Federal Circuit Judge Paul R. Michel warned the Ninth Circuit on Tuesday that reversing a lower court's decision to toss a pair of class actions accusing Invisalign of monopolizing the clear braces and teeth scanners market by illegally refusing to deal with a rival would increase patent owners' legal uncertainties.

  • October 29, 2024

    Roku Invalidates Smart Alarm Claims At Patent Board

    Roku Inc. has persuaded an administrative board at the patent office to wipe out six claims in a "smart" alarm device patent developed by a subsidiary of Roku's longtime rival, Universal Electronics Inc.

  • October 29, 2024

    DraftKings Denied $2.3M Fee Bid In Gambling Patent Row

    A Delaware federal judge on Tuesday denied DraftKings's $2.3 million fee bid for defeating Interactive Games' suit accusing it of infringing patents related to remote betting, ruling that Interactive Games' case isn't exceptional or frivolous since its patents were presumed valid and there's no evidence that Interactive Games was seeking quick settlements.

  • October 29, 2024

    ByteDance's Sanctions Bid Against Ex-Worker Delays Trial

    A California federal judge delayed a trial in a wrongful termination lawsuit filed by an engineer formerly at TikTok's parent company ByteDance, directing the parties on Tuesday to instead submit briefing on the defendants' motion to terminate the case as a sanction for the plaintiff's alleged destruction of evidence and perjury.

  • October 29, 2024

    Fed. Circ. Calls Plastic Co.'s IP Retrial Objection 'Frivolous'

    A panel of the Federal Circuit said Tuesday a plastic packaging manufacturer is making a "frivolous" objection to how a Massachusetts federal judge decided to set up a retrial scheduled next week over whether patents covering a kind of tamper-resistant container are invalid.

  • October 29, 2024

    PTAB Upholds Solar Co.'s Power Supply Patent

    The Patent Trial and Appeal Board has shot down a bid from a German solar energy technology company's U.S. unit to invalidate a competitor's solar power supply patent, the latest blow to the subsidiary in a larger patent fight.

  • October 29, 2024

    Lawmakers Want Update On Copyright Office's AI Reports

    The U.S. Copyright Office is late in submitting reports on the intersection of artificial intelligence and copyright law, according to a recent letter from leadership on the House committee with jurisdiction over the matter.

  • October 29, 2024

    Patent Partner Moves From King & Spalding To Steptoe

    A former King & Spalding LLP partner has made the jump to Steptoe LLP, filling out the firm's team of California-based litigators who take on patent cases.

  • October 29, 2024

    Baseball Bat Cos. Reach Deal To End Fla. Trademark Battle

    A baseball bat company owned by ex-MLB player Yoenis Céspedes has settled an intellectual property lawsuit against several businesses over baseball bats, months after a Florida federal judge handed the former New York Mets outfielder's business a preliminary injunction in the case.

  • October 29, 2024

    Allergan, Mankind Settle IP Fight Over Lumigan Generic

    Allergan Inc. and Mankind Pharma Ltd. asked a Delaware federal court Tuesday to dismiss infringement litigation over Mankind's proposed generic of Allergan's glaucoma drug Lumigan, stipulating that the patent is valid and has been infringed.

  • October 29, 2024

    Senate Panel Targets 'Clever' Pharma Pricing

    The Senate Judiciary Committee on Tuesday railed against drugmakers and pharmacy benefit managers for allegedly causing the high cost of prescription drugs, arguing that "Big Pharma" has used anticompetitive tactics through patenting to fleece American patients.

  • October 29, 2024

    Nokia, HP End Patent Litigation With Licensing Deal

    Finnish telecommunications giant Nokia has inked a multiyear patent-licensing deal with hardware manufacturer HP Inc. over its video technologies, pouring cold water on litigation between the pair in all jurisdictions, it announced Tuesday.

  • October 29, 2024

    Akerman Hires 2 IP Partners From Kilpatrick In NYC

    Akerman LLP announced Monday that two former partners at Kilpatrick Townsend & Stockton LLP are the latest additions to its intellectual property practice group in New York City.

  • October 29, 2024

    InterDigital Ends Legal Spats With Oppo In Licensing Deal

    InterDigital said Tuesday that it has inked a licensing agreement with Chinese smartphone giant Oppo that will bring an end to the cross-border litigation between the companies over patented smartphone technology.

  • October 29, 2024

    Ex-Boston University Law Prof Settles IP Suit With School

    A former Boston University School of Law instructor has settled a copyright infringement suit with the school that he filed in August accusing it of pilfering his course materials in violation of a prior settlement agreement.

  • October 29, 2024

    Front Office Sports Sued For Using Luxury Real Estate Photos

    Private equity-backed media outlet Front Office Sports is accused of unlawfully using luxury real estate photos online without permission, according to a lawsuit filed in New York federal court.

  • October 28, 2024

    $9M Fee Awarded For 'Feeble' Milk Vitamin Eligibility Row

    A Delaware federal judge entered a final judgment Monday ordering ChromaDex Inc. and Dartmouth College to pay $9.1 million in attorney fees to Elysium Health for making a "feeble" and failed argument defending their milk vitamin patents from an eligibility challenge.

Expert Analysis

  • 3 Patent Considerations For America's New Quantum Hub

    Author Photo

    Recent developments signal an incredibly bright future for Chicago as the new home of quantum computing, and it is crucial that these innovators — whose technology has the potential to transform many industries — prioritize intellectual property strategy, says Andrew Velzen at McDonnell Boehnen.

  • Fed. Circ. Ruling Creates New Rule For Certification Marks

    Author Photo

    The Federal Circuit's decision last month in Bureau National Interprofessionnel du Cognac v. Cologne & Cognac Entertainment is significant in that it establishes a new standard for assessing evidence of third-party uses of a certification mark in deciding whether the mark is famous, say Samantha Katze and Lisa Rosaya at Manatt.

  • A Preview Of AI Priorities Under The Next President

    Author Photo

    For the first time in a presidential election, both of the leading candidates and their parties have been vocal about artificial intelligence policy, offering clues on the future of regulation as AI continues to advance and congressional action continues to stall, say attorneys at Mintz.

  • 11 Patent Cases To Watch At Fed. Circ. And High Court

    Author Photo

    As we head into fall, there are 11 patent cases to monitor, touching on a range of issues that could affect patent strategy, such as biotech innovation, administrative rulemaking and patent eligibility, say Edward Lanquist and Wesley Barbee at Baker Donelson.

  • Why India May Become A Major Patent Litigation Forum

    Author Photo

    India is reinventing itself with the goal of becoming a global hot spot for patent litigation, with recent developments at the Delhi High Court creating incentives for plaintiffs to assert patent rights in India, say Ranganath Sudarshan at Covington and IP litigator Udit Sood.

  • Opinion

    To Lower Drug Prices, Harris Must Address Patent Thickets

    Author Photo

    If Vice President Kamala Harris is serious about her pledge to address high drug prices, she must begin by closing loopholes that allow pharmaceutical companies to develop patent thickets that can deter generic or biosimilar companies from entering the market, says Tahir Amin at the Initiative for Medicines, Access & Knowledge.

  • How Methods Are Evolving In Textualist Interpretations

    Author Photo

    Textualists at the U.S. Supreme Court are increasingly considering new methods such as corpus linguistics and surveys to evaluate what a statute's text communicates to an ordinary reader, while lower courts even mull large language models like ChatGPT as supplements, says Kevin Tobia at Georgetown Law.

  • 5 Ways To Confront Courtroom Technology Challenges

    Author Photo

    Recent cybersecurity incidents highlight the vulnerabilities of our reliance on digital infrastructure, meaning attorneys must be prepared to navigate technological obstacles inside the courtroom, including those related to data security, presentation hardware, video playback and more, says Adam Bloomberg at IMS Legal Strategies.

  • The Fed. Circ. In August: Secret Sales And Public Disclosures

    Author Photo

    Two recent Federal Circuit rulings — Sanho v. Kaijet and Celanese International v. ITC — highlight that inventors should publicly and promptly disclose their inventions, as a secret sale will not suffice as a disclosure, and file their patent applications within a year of public disclosure, say Sean Murray and Jeremiah Helm at Knobbe Martens.

  • Trending At The PTAB: Obviousness In Director Reviews

    Author Photo

    Three July decisions from the U.S. Patent and Trademark Office favoring petitioners indicate a willingness by the director to review substantive issues, such as obviousness, particularly in cases where the director believes the Patent Trial and Appeal Board provided incorrect or inadequate rationale to support its decisions, say attorneys at Finnegan.

  • AI Art Ruling Shows Courts' Training Data Cases Approach

    Author Photo

    A California federal court’s recent ruling in Andersen v. Stability AI, where the judge refused to throw out artists’ copyright infringement claims against four companies that make or distribute software that creates images from text prompts, provides insight into how courts are handling artificial intelligence training data cases, say attorneys at Skadden.

  • FTC Focus: What Access To Patent Settlements Would Mean

    Author Photo

    Settling parties should adopt a series of practice tips, including specifying rationales to support specific terms, as the Federal Trade Commission seeks to expand its access to settlements before the Patent Trial and Appeal Board, say Shannon McGowan and David Munkittrick at Proskauer.

  • Why Attorneys Should Consider Community Leadership Roles

    Author Photo

    Volunteering and nonprofit board service are complementary to, but distinct from, traditional pro bono work, and taking on these community leadership roles can produce dividends for lawyers, their firms and the nonprofit causes they support, says Katie Beacham at Kilpatrick.

  • Firms Must Offer A Trifecta Of Services In Post-Chevron World

    Author Photo

    After the U.S. Supreme Court’s Loper Bright Enterprises v. Raimondo decision overturning Chevron deference, law firms will need to integrate litigation, lobbying and communications functions to keep up with the ramifications of the ruling and provide adequate counsel quickly, says Neil Hare at Dentons.

  • Takeaways From UPC's Amgen Patent Invalidity Analysis

    Author Photo

    The Unified Patent Court Central Division's decision in Regeneron v. Amgen to revoke a patent for lack of inventive step is particularly clear in its reasoning and highlights the risks to patentees of the new court's central revocation powers, say Jane Evenson and Caitlin Heard at CMS.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!